The discovery of a catalytic RNA within RNase P and its legacy

Kirsebom, Leif A.; Liu, Fenyong; McClain, William H.

doi:10.1016/j.jbc.2024.107318

Journal of Biological Chemistry

2024

DOI: 10.1016/j.jbc.2024.107318

|View full text |Cite

The discovery of a catalytic RNA within RNase P and its legacy

Leif A. Kirsebom,

Fenyong Liu,

William H. McClain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

References 272 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

A tribute to Sidney Altman, one of the architects of modern RNA biology

Gopalan,

Kirsebom

2024

Journal of Biological Chemistry

Self Cite

View full text Add to dashboard Cite

A tribute to Sidney Altman, one of the architects of modern RNA biology

Gopalan,

Kirsebom

2024

Journal of Biological Chemistry

Self Cite

View full text Add to dashboard Cite

Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection

Smith,

Zhang,

Trang

et al. 2024

Viruses

View full text Add to dashboard Cite

Nucleic acid-based gene interference and editing strategies, such as antisense oligonucleotides, ribozymes, RNA interference (RNAi), and CRISPR/Cas9 coupled with guide RNAs, are exciting research tools and show great promise for clinical applications in treating various illnesses. RNase P ribozymes have been engineered for therapeutic applications against human viruses such as human cytomegalovirus (HCMV). M1 ribozyme, the catalytic RNA subunit of RNase P from Escherichia coli, can be converted into a sequence-specific endonuclease, M1GS ribozyme, which is capable of hydrolyzing an mRNA target base-pairing with the guide sequence. M1GS RNAs have been shown to hydrolyze essential HCMV mRNAs and block viral progeny production in virus-infected cell cultures. Furthermore, RNase P ribozyme variants with enhanced hydrolyzing activity can be generated by employing in vitro selection procedures and exhibit better ability in suppressing HCMV gene expression and replication in cultured cells. Additional studies have also examined the antiviral activity of RNase P ribozymes in mice in vivo. Using cytomegalovirus infection as an example, this review summarizes the principles underlying RNase P ribozyme-mediated gene inactivation, presents recent progress in engineering RNase P ribozymes for applications in vitro and in mice, and discusses the prospects of using M1GS technology for therapeutic applications against HCMV as well as other pathogenic viruses.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The discovery of a catalytic RNA within RNase P and its legacy

Cited by 2 publications

References 272 publications

A tribute to Sidney Altman, one of the architects of modern RNA biology

A tribute to Sidney Altman, one of the architects of modern RNA biology

Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection

Contact Info

Product

Resources

About